| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $6.58B | +21.3% |
| Cost of Revenue | $2.74B | +17.7% |
| Gross Profit | $3.84B | +24.0% |
| R&D Expense | $105.0M | +10.6% |
| SG&A Expense | $780.0M | +4.3% |
| Operating Income | $2.92B | +32.0% |
| Pre-tax Income | $1.72B | +52.3% |
| Income Tax | $417.0M | +59.8% |
| Net Income | $1.30B |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.47B | +15.7% |
| Accounts Receivable | $1.23B | +27.2% |
| Inventory | $1.62B | +21.3% |
| Current Assets | $6.74B | +19.3% |
| Total Assets | $19.97B | +10.3% |
| Current Liabilities | $1.58B | +10.7% |
| Long-term Debt | $19.40B | -0.2% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.38B | +45.0% |
| Capital Expenditures | $139.0M | +16.8% |
| Investing Cash Flow | -$900.0M | -62.7% |
| Financing Cash Flow | -$16.0M | +99.3% |
| Free Cash Flow | $1.24B | +49.1% |
| +49.9% |
| EPS (Basic) | $22.03 | +64.4% |
| EPS (Diluted) | $22.03 | +64.4% |
| Total Liabilities |
| $21.95B |
| +0.3% |
| Stockholders' Equity | -$1.98B | +47.4% |